https://pledge-tx.com/pledge-news/orthogon-therapeutics-announces-an-8m-follow-on-financing-to-advance-its-lead-bk-virus-drug/ 2025-11-10T16:05:34+00:00 https://pledge-tx.com/pledge-news/former-novartis-executive-dr-marie-lindner-joins-orthogon-therapeutics-board-of-directors/ 2025-11-10T16:06:49+00:00 https://pledge-tx.com/pledge-news/big-pharma-faces-a-cliff-edge-with-the-ongoing-crisis-in-ukraine/ 2025-11-10T16:07:20+00:00 https://pledge-tx.com/pledge-news/designing-anti-infectives-through-atomic-insights/ 2025-11-10T16:07:58+00:00 https://pledge-tx.com/pledge-news/orthogon-therapeutics-celebrates-major-technical-milestone-and-secures-additional-6m-toward-a-pioneering-drug-for-bk-virus/ 2025-11-10T16:08:29+00:00 https://pledge-tx.com/pledge-news/conformation-x-therapeutics-bolts-out-of-stealth-securing-over-13-5m-in-funding-to-propel-its-innovative-immune-oncology-pipeline/ 2025-11-10T16:08:59+00:00 https://pledge-tx.com/pledge-news/orthogon-therapeutics-closes-oversubscribed-5-2m-financing-to-advance-first-oral-therapy-for-bk-polyomavirus/ 2025-11-10T18:07:26+00:00